HDAC6 Inhibition Promotes Transcription Factor EB Activation and Is Protective in Experimental Kidney Disease

Overview of attention for article published in Frontiers in Pharmacology, February 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (65th percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 11,105 followers.

HDAC6 Inhibition Promotes Transcription Factor EB Activation and Is Protective in Experimental Kidney Disease. https://t.co/pmCdBB2rC2 https://t.co/LQRQ5W6h3T

RT @FrontPharmacol: HDAC6 Inhibition Promotes Transcription Factor EB Activation and Is Protective in Experimental Kidney Disease https://t…

RT @FrontPharmacol: HDAC6 Inhibition Promotes Transcription Factor EB Activation and Is Protective in Experimental Kidney Disease https://t…

HDAC6 Inhibition Promotes Transcription Factor EB Activation and Is Protective in Experimental Kidney Disease https://t.co/KyShBf2csi

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.